March 21, 2006 -- The US Food and Drug Administration (FDA) has approved first-time generic formulations of fluticasone propionate 50-µg nasal spray for the management of rhinitis symptoms in patients ...
A new nationwide recall has been issued for a generic version of the heartburn and ulcer drug Zantac due to the potential presence of an impurity that could cause cancer. It's the fourth recall for ...
Earlier this week, CVS, Rite Aid, and Walgreen’s suspended sales of Zantac (ranitidine) products. This follows the announcement last month by Sandoz, the generics division of Novartis, that it was ...
Details concerning the Ranitidine HCl combination medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, liquids, ...
A voluntary recall of a generic version of Zantac has been issued because the drug has been found to contain a contaminant that could cause cancer. Sandoz Inc. is recalling 14 lots of prescription ...
March 13, 2007 — The US Food and Drug Administration (FDA) has approved first-time generic formulations for rabeprazole sodium 20-mg delayed-release tablets and ranitidine HCl 15-mg/mL oral ...
(WAFB) - Updates issued by the U.S. Food and Drug Administration (FDA) Wednesday, Oct. 23 show more products used to relieve and prevent heartburn are being recalled due to the potential presence of ...
GSK has decided to voluntarily recall its ranitidine medication sold in global markets including India as a precautionary action pending the outcome of ongoing tests and investigations globally.
WASHINGTON — More common heartburn medications have been recalled due to the presence of an impurity that might cause cancer. Denton Pharma Inc. this week recalled several batches of ranitidine ...
Pharmaceuticals firm Zydus Cadila today said it has received final approval from US health regulator to market generic Ranitidine Hcl (hydroclhoride) injection used in treating peptic ulcers. Advisory ...
This information answers some common questions about Ranitidine Sandoz. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All ...
Highlights: - Indian pharma impacted by regulatory headwinds for Ranitidine - Formulators/API manufacturers to test data within 30 days - Indian formulators can have sales impact of ~5 percent if ban ...